most impact on endothelial-dependent microvascular function (1.7%, p=0.046 for SNP response; 19.3%, p<0.001 for ACh response). Time of sampling (11.2%, p<0.001), IL-6 (4.0%, p=0.002) and IL-10 (2.4%, p=0.018) were significant independent contributors to variation in endothelial-dependent microvascular function. When obesity was entered into the model the association with IL-6 and IL-10 were no longer significant and obesity explained 6.8% (p<0.001) of the variability in endothelial-dependent microvascular function. In the first trimester obese women had a significantly higher PAI-1/PAI-2 ratio (obese median [IQ range] 0.87 (0.54 -1.21) vs. lean 0.30 [0.21 -0.47], P<0.001) reflecting the lower PAI-2 levels in obese pregnant women. In a multivariate analysis, first trimester BMI (7.6%, p=0.012), IL-10 (8.2%, p<0.001) and sVCAM-1 (0.73%, p=0.007) contributed to first trimester PAI-1/PAI-2 ratio.
Conclusion: Obese mothers have a lower endothelium-dependent and -independent
vasodilation when compared to lean counterparts. There was a higher PAI-1/ PAI-2 ratio in the first trimester in obese women which improved later in pregnancy. Obese pregnancy is associated with chronic pre-existing endothelial activation and impairment of endothelial function secondary to increased production of inflammatory Th2 cytokines.
Introduction
Pre-pregnancy obesity is becoming a common occurrence in obstetric management. Changes in the treatment of obesity-related infertility have resulted in more of these women achieving a pregnancy. Furthermore, as estimated by the World Health Organisation in 2000, 300 million people worldwide are clinically obese. In the U.S. the incidence of obesity is reported to have risen from 13% to 27% between 1980 and 1999 (1) . American trends are now being seen among the European population with the prevalence of obesity in women in England rising from 16 .4% in 1993 to 23.8% in 2004 (2) . In line with this, our maternity hospital has observed a greater than two fold increase in the proportion of women with a booking body mass index (BMI) >30kg/m 2 over the past decade (3).
Increasing evidence relates impaired endothelial vasomotor function to coronary heart disease (4) . Endothelial function can be assessed in the peripheral circulation and this has been shown to correlate with endothelial function within the coronary circulation (5, 6) . Our group previously demonstrated that microvascular function in the third trimester of pregnancy (7) was better in lean compared to obese women. The study design however did not permit identification of the dynamics of this phenomenon, i.e. whether it was a pregnancy-specific effect.
In healthy pregnancy several components of the metabolic syndrome are acquired; insulin resistance, hypertriglyceridaemia, an upregulation of the inflammatory cascade and an increase in coagulation factors. These changes impact substantially not only on carbohydrate and lipid control pathways, but also on vascular endothelial function. Several soluble markers produced by the endothelium, once activated, can be measured in peripheral blood. These soluble markers of endothelial activation include the adhesion molecules ICAM-1 and VCAM-1 (8) , and the haemostatic factors vWF (9) and PAI-1 (10). The ratio of plasma levels of PAI-1 and PAI-2 (derived from the placenta) can be used as an index of placental function (11, 12) with a low index indicating good, and a high index indicating poor, placental function. The inflammatory response observed in pregnancy shifts from a Th1, mostly cellular, response to a Th2, mostly humoural response (13) and successful pregnancy is the result of a balance between the two responses. Some cytokines are more indicative of the Th1 response (TNFα) and some of the Th2 (IL-6) response. Interleukin 10 (IL-10) is an important cytokine produced by dendritic cells and T-cells. In particular, the Th3 cell population has a high production of IL-10 which polarises the immune response towards a Th2 type, and can suppress antigenspecific responses and mediate tolerance. The influence of obesity on these factors throughout pregnancy and in the post-natal period has not been assessed longitudinally.
We hypothesise that microvascular endothelial function is up-regulated in both lean and obese women with advancing gestation; however the degree of improvement will be less in obese women when compared to lean counterparts. The aim of the current study was to use a noninvasive measure of microvascular endothelial function, laser Doppler imaging (LDI), in lean and obese subjects at intervals throughout their pregnancy. We examined the relationship between changes in endothelial function with advancing gestation and BMI. In addition, we assessed plasma markers of endothelial function, inflammation (including TNFα/IL-6 ratio as an index of Th1/Th2 response) and placental function (PAI-1/PAI-2 ratio) and their association with microvascular function.
Methods

Subjects
Women (n=60) who registered for obstetric care at The Princess Royal Maternity Hospital, Glasgow, were recruited at their first visit at 10-12 weeks' gestation. Women were recruited as two groups, obese (BMI ≥ 30 kg/m 2 ) and lean (BMI < 30 kg/m 2 ) and groups were matched for age, smoking and parity. Exclusion criteria were a) a positive medical history, including obstetric history, of cardiac or metabolic disease and b) development of preeclampsia, gestational diabetes mellitus or any other metabolic complication of pregnancy during the index pregnancy. . The study was performed according to the Declaration of Helsinki, approval was granted by the Research Ethics Committee of North Glasgow University NHS Trust, and each subject gave written informed consent. The women were asked to attend after an overnight fast and underwent testing between 9 and 11am. Four examinations were performed in the first, second and third trimesters and at 4 months (at least 12 weeks) postpartum. Blood pressure was recorded at each visit using a standard sphygmomanometer and appropriately sized cuff. On the morning of the first examination the following parameters were recorded:
weight, height and waist circumference.
Assessment of endothelial function
Perfusion measurements were performed after an overnight fast ensuring no caffeinecontaining drinks had been consumed before testing. Also, no over-the-counter medications were taken by any of the participants for at least 48 h before testing. Before the examination commenced, a 10 minute period of acclimatisation in a temperature-controlled room was enforced. The women were asked to lie in a semi-recumbent position, with the flexor aspect of the forearm exposed on an armrest. Non-invasive measurement of skin perfusion was performed by means of a laser Doppler perfusion imaging (LDI) scanner (Moor Instruments Ltd, Axminster, UK) equipped with a red laser (wavelength, 633 nm; power, 1mW; beam diameter, 1 mm). The laser is scanned over the area to be examined, and backscattered light is collected by photo detectors and converted into a signal proportional to perfusion, in arbitrary perfusion units (PU). Twenty repetitive scans with an incremental iontophoretic current protocol were taken the first being a control (pre-current administration) followed by the incremental current protocol described below. Measurement of response to drugs was obtained by taking raw values but an assessment of the overall response was defined as the area under the perfusion x time curve (AUC). As previously described by our group (14) , correction for individual variation in skin resistance was performed by dividing by the integral of conductance (the reciprocal of resistance) over time or more simply by multiplying the individual perfusion values by the integral of resistance over time, thereby normalising responses.
Drug delivery was achieved using a battery-powered constant current iontophoresis controller (Moor Instruments Ltd, MIC-1e). The chambers used for iontophoresis (Moor Instruments Ltd, ION 6) were constructed of Perspex (internal diameter, 22 mm; area 3.8 cm 2 ) with an internal platinum wire electrode. Two chambers were attached to the skin of the volar aspect of the forearm, avoiding hair, broken skin and superficial veins. The protocol involved incremental current delivery, with a baseline scan followed by four scans at 5 µA, four at 10 µA, four at 15 µA, and two at 20 µA giving a total charge of 8 MilliCoulombs, followed by five recovery scans. Two and a half millilitres of 1% acetylcholine (Ach) (Sigma, Poole, UK), an endothelialdependent vasodilator, was introduced into the anodal chamber, while 2.5 ml of 1% sodium nitroprusside (SNP) (Sigma, Poole, UK), an endothelial-independent vasodilator, was placed in the cathodal chamber. The vehicle for these drugs was 0.5% sodium chloride (NaCl) in deionized water. Responses were also observed with the vehicle alone as a control experiment.
Based on the raw perfusion-time integrals, the mean (± SD) between-day CV for the ACh response, measured in four subjects on 2 separate days, was 6.4 ± 3.3%; whereas the withinday, between-site CV, measured in both forearms on the same morning in four subjects, was 8.9 ± 5.3% (14) .
Plasma Analysis
Plasma C Reactive protein (CRP) was quantified using a double antibody sandwich ELISA with rabbit anti-human CRP and peroxidase conjugated rabbit anti-human CRP: DAKO A/S, DK-2600 Glostrup, Denmark as described previously (15) . Plasma sICAM-1, sVCAM-1 and TNF-α were measured in citrated plasma and IL-6, and IL-10 in serum using high-sensitivity commercial ELISA kits (R&D Systems). PAI-1 and PAI-2 were assayed in citrated plasma using commercial ELISA according to manufacturers' instructions (TintElize, Alpha
Laboratories and Imubind, American Diagnostica, Axis Shield respectively). TNFα/IL-6 ratio was used as an index of Th1/Th2 response and PAI-1/PAI-2 ratio as an index of placental function.
Statistical analyses
Data were analysed as log 10 or square root transformed data as the raw values were not normally distributed. Dose response curves were expressed as mean ± SEM and were compared using two-way ANOVA. Post hoc analysis using Bonferroni correction was utilised.
Analysis was also performed using the area under the perfusion time curve (AUC). Two sample t tests were used to assess any significant differences between the lean and obese groups. Differences in endothelial function and inflammatory markers over time were tested using a repeated measures analysis in the general linear model (Minitab Vs 13.32). For multivariate analysis, the general linear model was used to examine the independent effects of time of sampling, obesity and plasma markers of inflammation and endothelial function on microvascular function, PAI-1/PAI-2 ratio, PAI-1 and PAI-2. Percent contribution to the variation (adjusted means squared, divided by the total means squared, expressed as a percentage) is quoted along with the level of significance.
Results
Patient characteristics
The demographics of the subject groups are shown in Table 1 . The groups were well matched for age, parity and smoking status. Of note both first trimester diastolic and systolic blood pressures, although remaining within the normal range, were significantly higher in the obese women. First trimester BMI as well as waist circumference were significantly different between the two groups. There was no significant difference in gestation, or number of weeks post partum, at each visit between the groups. Babies born to obese mothers had higher absolute birth weights and a significantly greater birth weight centile using converted centile charts when compared to those born to lean mothers. None of the women developed clinical evidence of hypertension or other metabolic complications of pregnancy.
Endothelial-dependent vasodilator response
The response to ACh (expressed as the AUC) showed a highly significant difference (P<0.001, 2-way ANOVA) between the lean and obese groups ( Fig 1A) . Post hoc analysis (Bonferroni correction) revealed that the response of the obese group was significantly lower (P<0.05) at each trimester (51%, 41% and 39% respectively) when compared to the lean group and when tested at 4 months post partum (115% lower; P<0.01). Two-way ANOVA revealed that the ACh response differed significantly (P<0.001) between the different time points, with the third trimester differing from the other time points (P<0.05, Bonferroni). Within the obese group, the third trimester response differed significantly from all other time points tested but within the lean group the third trimester response only differed significantly from second trimester response (P=0.04). Post partum, the ACh response did not decline significantly for the lean women but there was a significantly reduced response among the obese women (P<0.001).
Thus lean mothers have higher baseline endothelial-dependent function than obese mothers but the absolute improvement during pregnancy in endothelial-dependent function was similar in both groups (Fig 1A) , although the obese mothers still failed to match the level reached by the lean mothers. Lean mothers maintained this improvement in endothelial-dependent function in the post partum period whereas in obese women the endothelial-dependent function had declined to first trimester levels by 4 months post partum.
Endothelial-independent vasodilator response.
Analysis of SNP data revealed a similar pattern with time as the ACh response ( Fig 1B) with a highly significant difference between the time points tested (P<0.001, 2-way ANOVA).
However, within the lean group the third trimester response differed significantly from all other time points while among the obese women third trimester response differed only significantly from the second trimester and post-natal. There is also an overall small but significant difference between the two groups, the response of lean mothers being greater than obese mothers (p=0.021). Interestingly the post-natal SNP response declined significantly for both groups (P<0.001). Baseline endothelial-independent function was similar between groups, improving during pregnancy (Fig 1A) , and although the lean group appeared to show a greater response at the third trimester, this was not significant (P=0.27). For both lean and obese women endothelial-independent function had declined to near first trimester levels by 4 months post partum.
Soluble plasma markers of inflammation and endothelial activation
All of the measured inflammatory markers changed throughout pregnancy and the post-natal period apart from IL-10 in both groups and IL-6 in the obese (Table 2) . For TNFα, IL-10, sVCAM-1 and vWF there were no differences at any time point between the lean and obese groups. Only plasma CRP levels differed between lean and obese women at all time points tested with plasma CRP levels being significantly higher in the obese. Plasma IL-6 and sICAM-1 levels were significantly higher in obese women in early pregnancy (first and second trimester), but not in late pregnancy or the post-natal period ( Table 2) . PAI-1 levels were significantly lower in the obese in the first trimester and higher in the obese women in the postnatal period. PAI-2 levels were significantly lower in the obese in the first trimester.
TNFα is a cytokine indicative of the Th1 response whereas IL-6 is a cytokine indicative of the Th2 response. A ratio of TNFα/IL-6 was calculated to indicate the extent of the switch from the Th1 response to the Th2 response in pregnancy (Figure 2) . Lean women had a higher
TNFα/IL-6 ratio in the first trimester that declined in trimesters two and three and then rose in the post-natal period. In obese women the TNFα/IL-6 ratio did not change throughout pregnancy or in the post-natal period (p=0.26) and was significantly lower in obese than lean women at all time points apart from trimester three.
Relationships between endothelial function and markers of inflammation.
In a multivariate analysis using the general linear model, time of sampling and categorisation as lean or obese contributed to both endothelial-dependent and endothelial-independent microvascular function. .018) were significant independent contributors to variation in endothelial-dependent microvascular function. To test whether these inflammatory markers might explain the effect of obesity on endothelial-independent function, whether subjects were lean or obese was also entered in the multivariate model. IL-6 and IL-10 were no longer significant and obesity explained 6.8% (p<0.001) of the variability in endothelial-dependent microvascular function.
Index of placental function
PAI-1/PAI-2 ratio has been proposed as an index of placental function (11, 16) . PAI-1/PAI-2 ratios during pregnancy are shown in Figure 3 for lean and obese women. In the first trimester P<0.001). There were no differences in PAI-1/PAI-2 ratio in the second and third trimester.
The higher ratios seen in obese women in the first trimester predominately reflect the lower PAI-2 levels in trimester one rather than a higher PAI-1 level (Table 2) . Factors contributing to PAI-1/PAI-2 ratio, PAI-1 and PAI-2 variability in the first trimester were analysed in a
Discussion
We examined both in vivo microvascular function and markers of endothelial activation prospectively throughout pregnancy in healthy lean and obese women. Microvascular endothelial-dependent vasodilatory responses were found to be lower at all time points in obese subjects compared with lean counterparts and obesity had more impact on endothelialdependent than endothelial-independent microvascular function in multivariate analysis. These observations provide evidence of the detrimental effect of obesity on endothelial-dependent microvascular function, and that the effect is sustained throughout pregnancy. Our original hypothesis that endothelial function would be up-regulated to a greater degree during pregnancy in lean compared to obese women was not correct. Rather, endothelial-dependent function similarly increased in lean and obese women, but lean women started in the first trimester with significantly higher endothelial-dependent function and this difference from During pregnancy, maternal peripheral blood lymphocytes secrete more Th2 cytokines and less
Th1 cytokines than non-pregnant individuals (23). Furthermore trophoblast, decidua, chorionic
and amniotic membranes can all act as a source of Th2 cytokines (13) . Overall this leads to a change in the balance from Th1 to Th2 response that is typical of pregnancy (13) . We have previously shown that obese women have higher third trimester plasma levels of the Th2 cytokine IL-6 and of CRP, an inflammatory mediator whose production is induced by IL-6, in obese compared to lean pregnant women (7) . We expand this observation in the current study and show that plasma CRP levels are higher in obese compared to lean pregnant women at all time points measured and that plasma IL-6 and sICAM-1 levels are higher in early pregnancy in the obese. First trimester CRP was significantly higher than post-natal levels (P=0.001) indicating a very early increase of CRP levels associated with pregnancy, consistent with the report of elevated CRP levels at 4 weeks' gestation (24).
We used TNFα/IL-6 ratio as a guide to the relative contributions of the Th1 and Th2 response during pregnancy in the lean and obese individuals. In lean pregnant women we clearly see a high ratio in trimester 1, indicating more contribution from Th1 response. The ratio declines in the second and third trimester indicating a switch to a greater contribution from the Th2 response (Fig 2) . In the post-natal period the ratio switches back to a greater Th1 contribution.
Interestingly the obese women have a lower ratio than the lean women at all time points, apart from the third trimester, and the response to pregnancy is level. This suggests that the obese women are already predominately showing a Th-2 response and that there is no "Th1/Th2 switch" in pregnancy. It has been proposed, at least for preeclampsia, that an increase in maternal inflammatory response might provoke endothelial dysfunction (25). Using a multivariate model we found that none of the measured markers of inflammation or endothelial activation explained the endothelial-independent microvascular response. However endothelial-dependent microvascular function was predicted by IL-6 and IL-10 levels, an effect that was lost if presence of obesity was added into the model. This suggests that the excessive Th2 response observed in obese pregnant women is linked to their endothelial-dependent vascular dysfunction.
To our knowledge we have demonstrated for the first time the dynamics in PAI-1/ PAI-2 ratio with advancing gestation among lean and obese women. Plasma PAI-1 is derived from an activated endothelium and PAI-2 from a functioning placenta. A high index has been used to indicate poor placental function in studies of preeclampsia (12) whereas a low index would indicate good placental function. PAI-1/PAI-2 ratios were similar in later pregnancy (second and third trimester) in lean and obese women. However the PAI-1/PAI-2 ratio was hugely elevated (2.7 fold, p=0.001) in obese women in the first trimester. This was predominately due
to the approximately two-fold lower first trimester PAI-2 levels in the obese women. This raises the interesting possibility that, in the first trimester, placental growth/function is impaired in the obese pregnant woman but that a recovery in growth/function is achieved by the second trimester. In order to investigate possible mediators of this effect we carried out multivariate analysis of potential predictors of first trimester PAI-1 and PAI-2 levels. First trimester IL-10 levels predicted PAI-2 levels independent of BMI although this may merely indicate that placenta is a quantitatively important site of IL-10 production. It is possible that first trimester expression of a predominately Th2 response in obese individuals has adverse consequences for establishment of the placenta. An abnormally raised PAI-1/PAI-2 ratio also predates the onset of preeclampsia (12) In conclusion we have employed a well-tolerated, non-invasive technique for the assessment of endothelial function longitudinally throughout pregnancy. We have demonstrated reduced endothelium-dependent and -independent vasodilation among obese mothers when compared to lean counterparts. We observed a significantly higher PAI-1/ PAI-2 ratio in the first trimester in obese women; however these women went on during pregnancy to improve their PAI-1/PAI-2 ratio to levels comparable to their lean counterparts. We provide evidence that the increased risk of preeclampsia associated with obesity can be explained in part by chronic preexisting endothelial activation and impairment of endothelial function secondary to increased production of inflammatory Th-2 cytokines. We also hypothesise that early impaired placental growth/function is characteristic of obese pregnancy and if not recovered may further explain the elevated risk of hypertension and preeclampsia among obese mothers. Means and SE are shown. Ratios were significantly higher in the lean compared to the obese at all time points apart from trimester 3. TNFα/IL-6 ratio was used as an index of Th1/Th2 response. Ratios were significantly higher in the obese compared to the lean in the first trimester only. 
